Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.38M Buy
13,437
+2,337
+21% +$137K ﹤0.01% 2831
2026
Q1
$424K Buy
+11,100
New +$351K ﹤0.01% 3215
2025
Q4
Sell
-19,459
Closed -$418K 3570
2025
Q3
$418K Buy
+19,459
New +$436K ﹤0.01% 2901
2025
Q2
Sell
-11,489
Closed -$420K 3296
2025
Q1
$420K Buy
11,489
+1,659
+17% +$57.1K ﹤0.01% 2526
2024
Q4
$301K Sell
9,830
-6
-0.1% -$199 ﹤0.01% 2490
2024
Q3
$370K Sell
9,836
-943
-9% -$36.3K ﹤0.01% 2298
2024
Q2
$427K Buy
10,779
+1,578
+17% +$51.1K ﹤0.01% 2121
2024
Q1
$309K Sell
9,201
-886
-9% -$29.8K ﹤0.01% 2118
2023
Q4
$336K Buy
+10,087
New +$325K ﹤0.01% 2029
2022
Q3
Sell
-9,701
Closed -$398K 2193
2022
Q2
$398K Buy
9,701
+774
+9% +$37.6K ﹤0.01% 1763
2022
Q1
$517K Sell
8,927
-412
-4% -$22.5K ﹤0.01% 1809
2021
Q4
$549K Buy
9,339
+5,398
+137% +$328K ﹤0.01% 1794
2021
Q3
$239K Buy
+3,941
New +$231K ﹤0.01% 2104
2020
Q3
Sell
-4,760
Closed -$216K 2178
2020
Q2
$216K Buy
+4,760
New +$243K ﹤0.01% 1975
2019
Q4
Sell
-7,670
Closed -$278K 2114
2019
Q3
$278K Buy
+7,670
New +$323K ﹤0.01% 1928

Other funds holding ATEX

Cliff Asness's ATEX Position: Q2 2026 in Review

Cliff Asness increased its Anterix (ATEX) stake by 21% in Q2 2026, buying an estimated $137K and bringing the position to 13,437 shares worth $1.38M. The position accounts for ﹤0.01% of the portfolio, ranked #2831.

Cliff Asness first reported a position in ATEX in Q3 2019 and has held it in 15 quarters since. 171 funds tracked by Wall St. Rank hold ATEX as of Q2 2026.

  • Cliff Asness held 13,437 shares of Anterix worth $1.38M as of Q2 2026.
  • Cliff Asness bought 2,337 Anterix shares in Q2 2026, an estimated $137K.
  • Anterix made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #2831 holding.
  • Cliff Asness first reported a position in Anterix in Q3 2019 and has held it in 15 quarters since.
  • 171 funds tracked by Wall St. Rank held Anterix as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.